Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
Neuromodulation. 2010 Oct;13(4):265-8; discussion 269. doi: 10.1111/j.1525-1403.2010.00292.x.
We evaluated trends in inpatient spinal cord stimulation (SCS) for the 14-year period from 1993 to 2006.
We utilized the Nationwide Inpatient Sample data base from the Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality.
A total of 57,486 patients underwent inpatient placement of SCS systems from 1993 to 2006. Length of stay steadily decreased from 4.0 days in 1993 to 2.1 days in 2006. Average cost increased from $15,342 in 1993 to nearly $58,088 in 2006. The National Bill for SCS surgery in 2006 alone totaled nearly $215MM. Medicare accounted for 35% of payers, while private insurance accounted for 41% of claims.
Given the expense of these systems, it is important to assess not only the efficacy of novel neuromodulatory interventions, but also their cost. Future studies should be designed with these important outcome measures in mind.
我们评估了 1993 年至 2006 年 14 年来住院脊髓刺激 (SCS) 的趋势。
我们利用了医疗保健成本和利用项目、医疗保健研究和质量局的全国住院患者样本数据库。
1993 年至 2006 年期间，共有 57486 名患者接受了住院 SCS 系统植入。住院时间从 1993 年的 4.0 天稳步下降到 2006 年的 2.1 天。平均成本从 1993 年的 15342 美元增加到 2006 年的近 58088 美元。仅 2006 年的 SCS 手术国家账单就总计近 2.15 亿美元。医疗保险占支付者的 35%，而私人保险占索赔的 41%。
鉴于这些系统的费用，不仅要评估新的神经调节干预措施的疗效，还要评估其成本。未来的研究应该考虑到这些重要的结果衡量标准。
